Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Ankaferd Hemostat on Preventing Oral Mucositis in Colorectal Cancer Patients Receiving Chemotherapy

NCT05438771 is registered in ClinicalTrials.gov with Uludag University as lead sponsor.

NCT NCT05438771
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05438771 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Ankaferd Hemostat on Preventing Oral Mucositis in Colorectal Cancer Patients Receiving Chemotherapy
Lead sponsor
Uludag University
Phase
Not applicable
Overall status
Unknown status
Start date
June 1, 2021
Completion date
June 2, 2023
Enrollment
66 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy effect, colon cancer, nurse's role, oral mucositis